Skip to the content
Please enable JavaScript in your browser to complete this form.
Evaluation Form
Thank you for attending the BioMarin sponsored Virtual APAC Skeletal Dysplasia Summit 2022. Please take a moment to complete this brief evaluation survey.
1. The topics discussed in this meeting are relevant to my clinical practice
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
2. The webinar increased my understanding of the importance of early recognition and diagnosis of skeletal dysplasia
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
3. The webinar furthered my knowledge of using genetic testing to diagnose skeletal dysplasia
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
4. The date and time of the meeting were convenient for my schedule
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
5. The overall meeting was useful and interesting to me
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
6. Having joined the webinar, please select all statements that describe your confidence level in diagnosing skeletal dysplasia.
I feel confident recognising the early signs and symptoms of skeletal dysplasia
I feel confident formulating a diagnostic pathway for patients with suspected skeletal dysplasia
I feel confident identifying patients with suspected skeletal dysplasia who require referral for gene panel testing
None of the above
Submit
MMRC-MPSG-00146
October 2022